Project Grant R35GM163569
- Federal Project Grant Award Summary The University of Arizona received a $376,481 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2026, through March 31, 2031. The award supports research to develop bioinspired design principles for therapeutic microcarriers that resist immune clearance and biological filtration. The project addresses a significant clinical...
- Federal Project Grant Award Summary The University of Arizona received a $2.09 million Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 5, 2025, through September 4, 2029. This early-stage investigator-led research project will investigate the molecular mechanisms underlying commensal microbiota responses to host physiological stress. The research team will conduct...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Arizona a $1.835 million Project Grant on May 11, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop an ultra-broadband microscope based on innovative off-axis freeform reflective optical architecture. The project, scheduled for completion by April 30, 2030, will advance optical microscopy capabilities by addressing critical limitations of...
- Federal Project Grant Award Summary Arizona State University received a $1,977,264 Project Grant award, effective September 15, 2025, through August 31, 2029, under the National Institute of General Medical Sciences' Biomedical Research and Research Training program (CFDA 93.859). The award funds development of a novel multimodal imaging platform that integrates fluorescence super-resolution and tomographic polarized light imaging technologies to enable cellular and unicellular organism...
- Federal Project Grant Award Summary The University of Arizona received a $407,323 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) effective June 1, 2026, through May 31, 2031. This award supports fundamental research investigating glyoxalase 2 (GLO2) as a viable therapeutic target for treating diseases including sepsis, autoimmunity, cancer, and diabetes. The research focuses on...
- Federal Project Grant Award Summary Arizona State University's Office of Research and Sponsored Projects Administration (Orspa) received a $713,338 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through June 30, 2030. The award funds a five-year investigator-initiated research program investigating the mechanisms of mammal-microbial coevolution and its health...
- Federal Project Grant Award Summary Arizona State University received a $413,036 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2027. The award supports the development of a novel single-molecule glycosaminoglycan (GAG) sequencing method using fluorophore-labeled lysosomal enzymes. Glycosaminoglycans are large, linear, sulfated...
- Federal Project Grant Award Summary The University of Chicago received a $451,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with completion targeted for January 31, 2031. The award funds a five-year research initiative investigating the regulatory mechanisms controlling desiccation tolerance in Acinetobacter baumannii, an emerging opportunistic bacterial pathogen....
- Federal Project Grant Award Summary The University of Michigan's Regents, through its Office of Research and Sponsored Projects, received a $426,539 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award, obligated on May 1, 2026, with a completion date of February 28, 2031, funds research into context-specific cellular networks in bacterial pathogens, specifically investigating...
- Federal Grant Award Summary Arizona State University received a $847,599 Project Grant award from the National Science Foundation's Division of Molecular and Cellular Biosciences (CFDA 47.074) effective September 1, 2025, through August 31, 2028, to conduct collaborative research on the structural and functional mechanisms of bacterial gliding motility. The project will investigate how soil bacteria utilize specialized molecular machinery—specifically rotating motors that drive a protein-based...
The University of Arizona received a $410,775 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), with an award date of July 1, 2026, and a completion date of March 31, 2031. Under the direction of Principal Investigator Prof. Riedel-Kruse, this research project advances synthetic biology by developing engineered bacterial synthetic cell-cell adhesion tools and genetic circuits to enable the controlled assembly and patterning of multi-cellular bacterial consortia. The research focuses on protein engineering to enhance synthetic adhesion capabilities, development of novel genetic circuits for controlled patterning, engineering of consortia for health-relevant applications such as improved drug biosynthesis and living materials, and integration of experimental work with biophysical modeling across multiple scales. The project deliverables encompass both fundamental scientific advances and practical applications in basic research and health. Key products include improved synthetic adhesion toolboxes with novel engineered features, synthetic genetic circuits enabling controlled multi-cellular consortium patterning, engineered bacterial consortia demonstrating feasibility for drug biosynthesis and synthetic biomaterial development, and biophysical models characterizing the engineered systems. This work directly addresses a previous gap in bacterial synthetic biology by providing practical tools and methodologies for engineering multi-cellular microbial systems, with applications extending to modular drug production, living diagnostic devices, and synthetic biofilm research models.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $410.8k | 6/29/26 |